Showing results (411-420 of 1,005) with videos related to

Sort By:
Pageof 101
Ejhaem|July 8, 2025
Bleeding Complications in JAK2-Variant Essential Thrombocythemia: A Revisit in 2025Gerard Gurumurthy, Samantha Gurumurthy, Tim C P Somervaille, et al.
Ejhaem|June 27, 2025
Characteristics, Treatment Patterns, and Outcomes of Patients with Multiple Myeloma, Including Those Who are Triple-Class Exposed: A Retrospective Cohort Study in England Using National Cancer Registry DataCarmen Tsang, Kellyn Arnold, Charles Duffield, et al.
Ejhaem|June 9, 2025
Direct Oral Anticoagulants Compared to Warfarin in Patients with Intermediate- to High-Risk Pulmonary Embolism: A Systematic Review and Meta-AnalysisMohamed Nabil Elshafei, Muhammad Salem, Mutasem Almistarihi, et al.
Ejhaem|June 9, 2025
Final Results of a Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple MyelomaBarry Paul, Jiri Minarik, Francesca Cottini, et al.
Ejhaem|June 20, 2025
Novel Flavonoid Derivatives Show Potent Efficacy in Human Lymphoma ModelsEugenio Gaudio, Paulina Biniecka, Alberto J Arribas, et al.
Ejhaem|February 26, 2024
Atypical meningeal localization of classical hairy cell leukemia with an impressive response to rituximab and cladribine association. A case report and literature reviewFabien Claves, Sylvain Carras, Barbara Burroni, et al.
Ejhaem|February 26, 2024
Real-life effectiveness of carfilzomib in patients with relapsed multiple myeloma receiving treatment in the context of early access: The CARMYN studyKamel Laribi, Xavier Leleu, Nathalie Texier, et al.
Ejhaem|February 26, 2024
Haemoglobin Ottawa, sickle cell trait and vaso-occlusive crisesCécile Bobillier, Isabelle Derclaye, Augustin Ferrant, et al.
Ejhaem|February 26, 2024
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosisStephen T Oh, Srdan Verstovsek, Vikas Gupta, et al.
Ejhaem|February 26, 2024
The potential of 3rd-generation nanopore sequencing for B-cell clonotyping in lymphoproliferative disordersMarcus H Hansen, Oriane Cédile, Niels Abildgaard, et al.
Pageof 101